Your browser doesn't support javascript.
loading
Phase 1 open-label trial of intravenous administration of MVA-BN-brachyury-TRICOM vaccine in patients with advanced cancer.
DeMaria, Peter J; Lee-Wisdom, Katherine; Donahue, Renee N; Madan, Ravi A; Karzai, Fatima; Schwab, Angie; Palena, Claudia; Jochems, Caroline; Floudas, Charalampos; Strauss, Julius; Marté, Jennifer L; Redman, Jason Mark; Dombi, Eva; Widemann, Brigitte; Korchin, Borys; Adams, Tatiana; Pico-Navarro, Cesar; Heery, Christopher; Schlom, Jeffrey; Gulley, James L; Bilusic, Marijo.
Afiliación
  • DeMaria PJ; Genitourinary Malignancies Branch, National Cancer Institute, National Institutes of Health, Bethesda, Maryland, USA.
  • Lee-Wisdom K; Medical Oncology Service, Center for Cancer Research, National Cancer Institute, National Institutes of Health, Bethesda, Maryland, USA.
  • Donahue RN; Laboratory of Tumor Immunology and Biology, National Cancer Institute, Bethesda, Maryland, USA.
  • Madan RA; Genitourinary Malignancies Branch, National Cancer Institute, National Institutes of Health, Bethesda, Maryland, USA.
  • Karzai F; Genitourinary Malignancies Branch, National Cancer Institute, National Institutes of Health, Bethesda, Maryland, USA.
  • Schwab A; Laboratory of Tumor Immunology and Biology, National Cancer Institute, Bethesda, Maryland, USA.
  • Palena C; Laboratory of Tumor Immunology and Biology, National Cancer Institute, Bethesda, Maryland, USA.
  • Jochems C; Laboratory of Tumor Immunology and Biology, National Cancer Institute, Bethesda, Maryland, USA.
  • Floudas C; Genitourinary Malignancies Branch, National Cancer Institute, National Institutes of Health, Bethesda, Maryland, USA.
  • Strauss J; Laboratory of Tumor Immunology and Biology, National Cancer Institute, Bethesda, Maryland, USA.
  • Marté JL; Genitourinary Malignancies Branch, National Cancer Institute, National Institutes of Health, Bethesda, Maryland, USA.
  • Redman JM; Genitourinary Malignancies Branch, National Cancer Institute, National Institutes of Health, Bethesda, Maryland, USA.
  • Dombi E; Pediatric Oncology Branch, National Cancer Institute, Bethesda, Maryland, USA.
  • Widemann B; Pediatric Oncology Branch, National Cancer Institute, Bethesda, Maryland, USA.
  • Korchin B; Oncology Strategy, Bavarian Nordic Inc, Morrisville, North Carolina, USA.
  • Adams T; Bavarian Nordic GmbH, Martinsried, Bayern, Germany.
  • Pico-Navarro C; Oncology Strategy, Bavarian Nordic Inc, Morrisville, North Carolina, USA.
  • Heery C; Arcellix, Inc, Gaithersburg, Maryland, USA.
  • Schlom J; Laboratory of Tumor Immunology and Biology, National Cancer Institute, Bethesda, Maryland, USA.
  • Gulley JL; Genitourinary Malignancies Branch, National Cancer Institute, National Institutes of Health, Bethesda, Maryland, USA.
  • Bilusic M; Genitourinary Malignancies Branch, National Cancer Institute, National Institutes of Health, Bethesda, Maryland, USA marijo.bilusic@nih.gov.
J Immunother Cancer ; 9(9)2021 09.
Article en En | MEDLINE | ID: mdl-34479925
Asunto(s)
Palabras clave
Texto completo
Imprimir
XML
PubMed Links
Buscar en Google

Texto completo: 1 Bases de datos: MEDLINE Asunto principal: Vacunas contra el Cáncer / Proteínas de Dominio T Box / Proteínas Fetales / Administración Intravenosa / Inmunoterapia / Neoplasias Límite: Female / Humans / Male / Middle aged Idioma: En Revista: J Immunother Cancer Año: 2021 Tipo del documento: Article País de afiliación: Estados Unidos
Texto completo
Imprimir
XML
PubMed Links
Buscar en Google

Texto completo: 1 Bases de datos: MEDLINE Asunto principal: Vacunas contra el Cáncer / Proteínas de Dominio T Box / Proteínas Fetales / Administración Intravenosa / Inmunoterapia / Neoplasias Límite: Female / Humans / Male / Middle aged Idioma: En Revista: J Immunother Cancer Año: 2021 Tipo del documento: Article País de afiliación: Estados Unidos